Tonix Pharmaceuticals Holding Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

SALE OF COMMON STOCK (Details Narrative)

SALE OF COMMON STOCK (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands							3 Months Ended
	Dec. 13, 2018	Dec. 11, 2018	Dec. 07, 2018	Oct. 18, 2018	May 01, 2018	Sep. 28, 2017	Mar. 31, 2019	Mar. 31, 2018
Number of options granted							113,400
Gross proceeds from stock issuance								$ 532
Series A Convertible Preferred Stock [Member]
Conversion of preferred stock (shares)							9,856
Shares issue upon conversion of preferred stock (shares)							2,816,000
Purchase Agreement and Registration Rights Agreement [Member] \| Lincoln Park Capital Fund, LLC ("Lincoln Park") [Member]
Commitment to purchase shares under agreement				$ 15,000,000		$ 15,000,000
Issuance of common stock for commitment to purchase				$ 245		$ 300,000
Issuance of common stock for commitment to purchase (shares)				35,000		7,304
Limitation on sale of common shares outstanding (percent)						19.99%
Limitation on sale of common shares outstanding (shares)						150,000
2016 Sales Agreement [Member] \| Cowen and Company LLC [Member] \| At-The-Market Offering [Member]
Offering price per agreement								15,000
Payment of commision								$ 300
Sales Agreement [Member] \| Cowen and Company LLC [Member] \| At-The-Market Offering [Member]
Offering price per agreement					$ 9,500
Percentage of selling commission					3.00%
Underwriting Agreement [Member] \| Alliance Global Partners Dawson And James Securitie Inc [Member] \| Class A Units [Member]
Share price (in dollars per share)			$ 3.50
Number of common shares per unit			1
Number of warrants to purchase to common stock per unit			1
Underwriting Agreement [Member] \| Class A Units [Member] \| Alliance Global Partners Dawson And James Securitie Inc [Member]
Issuance of common stock and common stock warrants in December 2018 (in shares)			861,710
Number of options granted			642,856
Number of options granted, term			45 days
Number of warrants granted			642,856
Underwriting Agreement [Member] \| Class B Units [Member] \| Alliance Global Partners Dawson And James Securitie Inc [Member]
Issuance of Series A Convertible preferred stock and common stock warrants in December 2018 (in shares)			11,984
Share price (in dollars per share)			$ 1,000
Number of warrants to purchase to common stock per unit			285.7143
Number of convertible preferred stock per unit			1
Warrants expiration period			5 years
Conversion price per share			$ 3.50
Underwriting Agreement [Member] \| Public Offering [Member] \| Class A Units [Member] \| Alliance Global Partners Dawson And James Securitie Inc [Member]
Net proceeds from issuance of common stock		$ 13,600
Underwriting discount		$ 1,100
Underwriting discount per share (in dollars per share)		$ 0.24
Discount to the public offering price		7.00%
Underwriting discount and other offering expenses		$ 400
Underwriting Agreement [Member] \| Over-Allotment Option [Member] \| Alliance Global Partners Dawson And James Securitie Inc [Member]
Number of shares issued	250,000
Net proceeds from issuance of common stock	$ 800
Underwriting discount	$ 100
Underwriting discount per share (in dollars per share)	$ 0.24
Underwriting Agreement [Member] \| Over-Allotment Option [Member] \| Class A Units [Member] \| Alliance Global Partners Dawson And James Securitie Inc [Member]
Number of shares issued		640,000
Net proceeds from issuance of common stock		$ 6
2017 Purchase Agreement [Member] \| Lincoln Park Capital Fund, LLC ("Lincoln Park") [Member]
Number of shares issued							18,000
Gross proceeds from stock issuance							$ 600